Thioridazine Hydrochloride

盐酸硫利达嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameThioridazine Hydrochloride
Drug Alias Name盐酸硫利达秦盐酸硫利哒嗪盐酸甲硫达嗪盐酸甲硫哒嗪盐酸硫醚嗪 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryUnited States
Original Approved Date1962/03/15
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesHunan Dongting Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharma Ag
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05AC02
Related LinksWikipediaDrugBankKEGG